Nanging
Lancet 360:384, Ng, J. &Frith, R., 2002
The Behavioral Spectrum of Tic Disorders
Neurol 59:414-420, Kurlan,R.,et al, 2002
Nonmotor Fluctuations in Parkinson's Disease
Neurol 59:408-413, Witjas,T.,et al, 2002
Cognitive and Behavioral Outcomes of School-Aged Children Who Were Born Preterm
JAMA 288:728-737, Bhutta,A.T.,et al, 2002
Orbital Infarction After Cocaine Use
Neurol 59:642, Van Stavern,G.P. &Gorman,M., 2002
Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002
Clinicopath Conf, Neuronal Ceroid Lipofuscinosis, Late-Onset Infantile Subtype
NEJM 347:672-680, Case 27-2002, 2002
Acute Disseminated Encephalomyelitis
Neurol 59:1224-1231, Tenembaum,S.,et al, 2002
Features of Medication Overuse Headache Following Overuse of Different Acute Headache Drugs
Neurol 59:1011-1014,972, Limmroth,V.,et al, 2002
Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002
Seizure Induced by Insufflation of Bupropion
NEJM 347:951, Welsh,C.J. &Doyon,S., 2002
Prognosis for Gross Motor Function in Cerebral Palsy
JAMA 288:1357-1363,1399, Rosenbaum,P.L., et al, 2002
Effect of Radiotherapy and Other Treatment-Related Factors on Mid-Term to Long-Term Cognitive Sequelae in Low-Grade Gliomas: A Comparative Study
Lancet 360:1361-1368, Klein,M.,et al, 2002
Dose-Related Neurocognitive Effects of Marijuana Use
Neurol 59:1337-1343,1295, Bolla,K.I.,et al, 2002
Burning Mouth Syndrome
Am Fam Physician 65:615-620, Gruska,M.,et al, 2002
Subacute Sclerosing Panencephalitis
Postgrad Med J 78:63-70, Garg, R.K.,et al, 2002
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002
A Longitudinal Study of Abnormalities on MRI and Disability From Multiple Sclerosis
NEJM 346:158-164,199, Brex,P.A.,et al, 2002
Predictors of Functional Disability and Mortality After Status Epilepticus
Neurol 58:139-142, Claassen,J.,et al, 2002
Cerebral Vasoconstriction and Stroke After Use of Serotonergic Drugs
Neurol 58:130-133, Singhal,A.B.,et al, 2002
Outcome of and Prognostic Factors for Herpes Simplex Encephalitis in Adult Patients: Results of a Multicenter Study
Clin Inf Dis 35:254-260, Raschillas, F.,et al, 2002
Cyclists doping associated with cerebral sinus thrombosis
Neurol 58:665, Martinez Lage, J.M.,et al, 2002
Delirium From Nicotine Withdrawal in Neuro-ICU Patients
Neurol 57:551-553, Mayer,S.A.,et al, 2001
High-Dose Estradiol Improves Cognition for Women with AD, Results of a Randomized Study
Neurol 57:605-612, Asthana,S.,et al, 2001
Effects of Ecstasy (MDMA) on the Brain in Abstinent Users:Initial Observations with Diffusion and Perfusion MR Imaging
Radiology 220:611-617, Reneman,L.,et al, 2001
Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001
Dysgeusia in Epileptic Patients Treated with Lamotrigine: Report of Three Cases
Neurol 57:1521, Avoni,P.,et al, 2001
Surgical Therapy for Tremor in Multiple Sclerosis
Neurol 57:1876-1882, Matsumoto,J.,et al, 2001
Evidence Based Management of Attention Deficit Hyperactivity Disorder
BMJ 323:1232-1235, Guevara,J.P. &Stein,M.T., 2001
Multiple Sclerosis and Magnetic Resonance Imaging
Arch Neurol 58:35-36, Racke,M.K.,et al, 2001
Longitudinal Assessment of Neurocognitive Function After Coronary-Artery Bypass Surgery
NEJM 344:395-402,451, Newman,M.F.,et al, 2001
APOE Genotype is a Major Predictor of Long-Term Progression of Disability in MS
Neurol 56:312-316, Chapman,J.,et al, 2001
La Crosse Encephalitis in Children
NEJM 344:801-807, McJunkin,J.E.,et al, 2001
Disability and Quality of Life in Charcot-Marie-Tooth Disease Type 1
JNNP 70:548-550, Pfeiffer,G.,et al, 2001
Comparisons of Patient Self-report, Neurologic Examination, and Functional Impairment in MS
Neurol 56:934-937, Hoogervorst,E.L.J.,et al, 2001
Cocaine-Induced Persistent Dyskinesias
Neurol 56:964-965, Weiner,W.J.,et al, 2001
Memory Impairment in Abstinent MDMA ("Ecstasy") Users: A Longitudinal Investigation
Neurol 56:966-969, Zakzanis,K.K. & Young,D.A., 2001
Clinicopath Conf, Strychnine Poisoning, Case 12-2001
NEJM 344:1232-1239, , 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001
Adverse Long-term Effects of Brain Radiotherapy in Adult Low-grade Glioma Patients
Neurol 56:1285-1290,1255, Surma-aho,O.,et al, 2001
Handicap After Acute Whiplash Injury
Neurol 56:1637-1643, Kasch,H.,et al, 2001
Return to Driving After Head Injury
JNNP 70:761-766, Hawley,C.A., 2001
PRISMS-4: Long-Term Efficacy of Interferon-B-1a in Relapsing MS
Neurol 56:1628-1636,1620, The PRISMS Study Group, 2001
Onset of Multiple Sclerosis Associated With Anti-TNF Therapy
Neurol 57:1885-1888, Sicotte,N.L. &Voskuhl,R.R., 2001
Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001
Moyamoya-like Vasculopathy from Cocaine Dependency
AJNR 21:1008-1010, Storen,E.C.,et al, 2000
Reduced Signal Intensity of T2 Weighted MR Imaging of Thalamus and Putamen in Multiple Sclerosis in Japan
Rinsho Shinkeigaku 40:677-682, Nishii,T.,et al, 2000